Pfizer Withdraws COVID Vaccine Application in India After Regulators Demand Local Safety and Immunogenicity Study
Pfizer pulled its application for emergency-use authorization of its COVID-19 vaccine in India after the country’s pharmaceutical regulator’s demand for a local safety and immunogenicity study, Reuters reported. On February 3, India’s COVID-19 Subject Expert Committee (SEC) reviewed the data
Read More